Tocqueville Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$710K	Sell	4,200 -200	-5%	-$34.5K	0.01%	399
2025 Q4	$804K	Sell	4,400 -1,250	-22%	-$175K	0.01%	401
2025 Q3	$686K	Buy	5,650 +450	+9%	+$50.7K	0.01%	400
2025 Q2	$543K	Hold	5,200	–	–	0.01%	411
2025 Q1	$606K	Buy	5,200 +250	+5%	+$28.5K	0.01%	390
2024 Q4	$419K	Sell	4,950 -150	-3%	-$13.8K	0.01%	441
2024 Q3	$458K	Sell	5,100 -100	-2%	-$8.73K	0.01%	415
2024 Q2	$419K	Sell	5,200 -1,100	-17%	-$81.4K	0.01%	422
2024 Q1	$503K	Sell	6,300 -400	-6%	-$33.6K	0.01%	408
2023 Q4	$533K	Buy	6,700 +500	+8%	+$33.4K	0.01%	389
2023 Q3	$433K	Sell	6,200 -1,000	-14%	-$74.8K	0.01%	415
2023 Q2	$517K	Hold	7,200	–	–	0.01%	410
2023 Q1	$444K	Hold	7,200	–	–	0.01%	421
2022 Q4	$555K	Buy	7,200 +100	+1%	+$5.98K	0.01%	430
2022 Q3	$317K	Buy	+7,100	New	+$355K	0.01%	507
2020 Q3	–	Sell	-2,500	Closed	-$206K	–	651
2020 Q2	$206K	Buy	+2,500	New	+$192K	﹤0.01%	622